MarketPeel
Insider Trading Intelligence
BL

Brent T. Lucas

COCH
CHIEF EXECUTIVE OFFICER · ENVOY MEDICAL, INC. · CIK 0001994382
FILING MIX · LIFETIME100%/0%
BUYS
17
SELLS
0
TOTAL VALUE
$95.8K
COMPANIES
1
ACTIVE SINCE
Oct 2023
HOLDINGS NOW
1,000,000
AVG SELL PX
TRADE KIND
SHOWING 17 / 17
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
7 backtested trades · 8 horizons · 11 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Brent T. Lucas, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d7+71.43%+34.46%-0.69%+35.15%+39.80%
14d7+71.43%+33.10%+0.52%+32.58%+32.60%
30d7+71.43%+50.06%-1.02%+51.09%+53.74%
60d7+71.43%+11.69%+2.24%+9.45%+20.66%
90d7+71.43%+8.15%+4.37%+3.78%+16.57%
180d7(3 pending)+50.00%+100.87%+8.56%+92.31%+92.31%
1y7(3 pending)+50.00%+29.76%+23.11%+6.65%+6.65%
2y7(5 pending)+0.00%-28.14%+46.84%-74.98%-74.98%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
COCH · 1,000,000 shares · as of Jun 19, 2026
0250,000500,000750,0001,000,000202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 17 buys / 0 sellsCOVERAGE · 11 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
COCH
ENVOY MEDICAL, INC.
PURCHASEGRANT
Stock grant
1,000,0001,000,000Jun 19, 2026Jun 23, 2026View →
COCH
ENVOY MEDICAL, INC.
PURCHASEGRANT
Stock grant
1,000,0001,000,000Jun 19, 2026Jun 23, 2026View →
COCH
ENVOY MEDICAL, INC.
PURCHASEGRANT
Stock grant
32,856$0.60$19.7K329,946May 29, 2026Jun 3, 2026View →
COCH
ENVOY MEDICAL, INC.
PURCHASE
Chief Executive Officer
62,500$0.40$25.0K297,090Feb 12, 2026Feb 16, 2026View →
COCH
ENVOY MEDICAL, INC.
PURCHASE
Chief Executive Officer
62,50062,500Feb 12, 2026Feb 16, 2026View →
COCH
ENVOY MEDICAL, INC.
PURCHASE
Chief Executive Officer
37,50037,500Feb 12, 2026Feb 16, 2026View →
COCH
ENVOY MEDICAL, INC.
PURCHASEGRANT
Stock grant
200,000200,000Feb 5, 2026Feb 9, 2026View →
COCH
ENVOY MEDICAL, INC.
PURCHASEGRANT
Stock grant
18,105$0.71$12.9K234,590Nov 28, 2025Dec 10, 2025View →
COCH
ENVOY MEDICAL, INC.
PURCHASEGRANT
Stock grant
7,742$1.29$10.0K216,485May 30, 2025Jun 9, 2025View →
COCH
ENVOY MEDICAL, INC.
PURCHASE
Chief Executive Officer
16,694$0.06$1.0K110,987Dec 11, 2024Dec 13, 2024View →
COCH
ENVOY MEDICAL, INC.
PURCHASE
Chief Executive Officer
94,293$0.06$5.2K94,293Dec 11, 2024Dec 13, 2024View →
COCH
ENVOY MEDICAL, INC.
PURCHASEGRANT
Stock grant
5,165$1.94$10.0K208,743Nov 30, 2024Jun 9, 2025View →
COCH
ENVOY MEDICAL, INC.
PURCHASE
Chief Executive Officer
74,784195,615Jun 24, 2024Jun 26, 2024View →
COCH
ENVOY MEDICAL, INC.
PURCHASE
Chief Executive Officer
10,17612,720Jun 24, 2024Jun 26, 2024View →
COCH
ENVOY MEDICAL, INC.
PURCHASE
Chief Executive Officer
10,000$0.98$9.8K118,451Nov 21, 2023Nov 24, 2023View →
COCH
ENVOY MEDICAL, INC.
PURCHASE
Chief Executive Officer
2,380$0.92$2.2K120,831Nov 21, 2023Nov 24, 2023View →
COCH
ENVOY MEDICAL, INC.
PURCHASEGRANT
Stock grant
879,749879,749Oct 15, 2023Oct 17, 2023View →
Other insiders · COCH
Loading peer insiders…
About this filer
CIK 0001994382
ROLE
Chief Executive Officer
PRIMARY
COCH
COMPANIES
1
ACTIVE SINCE
Oct 2023
MARKETPEEL · /INSIDER/0001994382DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback